NASDAQ:HBIO
Harvard Bioscience Stock News
$3.75
-0.170 (-4.34%)
At Close: May 07, 2024
Harvard Bioscience Announces Second Quarter 2022 Financial Results
02:48am, Thursday, 04'th Aug 2022 GlobeNewswire Inc.
HOLLISTON, Mass., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the second quarter ended June 30, 2022.
Bruker (BRKR) Meets Q2 Earnings Estimates
09:45pm, Wednesday, 03'rd Aug 2022 Zacks Investment Research
Bruker (BRKR) delivered earnings and revenue surprises of 0% and 0.43%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Harvard Bioscience Schedules Second Quarter 2022 Earnings Conference Call for August 4, 2022 at 8:00 AM ET
08:50pm, Tuesday, 26'th Jul 2022 GlobeNewswire Inc.
HOLLISTON, Mass., July 26, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for second quarter ended June 30, 2022 before the market opens on Augu
Harvard Bioscience Schedules Second Quarter 2022 Earnings Conference Call for August 4, 2022 at 8:00 AM ET
04:50pm, Tuesday, 26'th Jul 2022
HOLLISTON, Mass., July 26, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for second quarter ended June 30, 2022 before the market opens on August
Are Options Traders Betting on a Big Move in Harvard Bioscience (HBIO) Stock?
12:40pm, Wednesday, 15'th Jun 2022 Zacks Investment Research
Investors need to pay close attention to Harvard Bioscience (HBIO) stock based on the movements in the options market lately.
Harvard Bioscience (HBIO) Loses 35.7% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
01:35pm, Monday, 16'th May 2022 Zacks Investment Research
Harvard Bioscience (HBIO) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings
Harvard Bioscience (HBIO) Loses 35.7% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
11:17am, Monday, 16'th May 2022
Harvard Bioscience (HBIO) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings
Harvard Bioscience, Inc. (HBIO) CEO James Green on Q1 2022 Results - Earnings Call Transcript
12:36pm, Wednesday, 04'th May 2022
Harvard Bioscience, Inc. (NASDAQ:HBIO ) Q1 2022 Earnings Conference Call May 4, 2022 8:00 AM ET Company Participants David Sirois - Director of Corporate Accounting & SEC Reporting James Green - Presi
Harvard Bioscience (HBIO) Q1 Earnings and Revenues Lag Estimates
12:25pm, Wednesday, 04'th May 2022 Zacks Investment Research
Harvard Bioscience (HBIO) delivered earnings and revenue surprises of -20% and 1.11%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Harvard Bioscience Announces First Quarter 2022 Financial Results
11:00am, Wednesday, 04'th May 2022 GlobeNewswire Inc.
HOLLISTON, Mass., May 04, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the first quarter ended March 31, 2022.
Harvard Bioscience (HBIO) Q1 Earnings and Revenues Lag Estimates
09:47am, Wednesday, 04'th May 2022
Harvard Bioscience (HBIO) delivered earnings and revenue surprises of -20% and 1.11%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
PerkinElmer (PKI) Beats Q1 Earnings and Revenue Estimates
09:25pm, Tuesday, 03'rd May 2022 Zacks Investment Research
PerkinElmer (PKI) delivered earnings and revenue surprises of 15.87% and 6.70%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Harvard Bioscience Schedules First Quarter 2022 Earnings Conference Call for May 4, 2022 at 8:00 AM ET
08:05pm, Thursday, 21'st Apr 2022 GlobeNewswire Inc.
HOLLISTON, Mass., April 21, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for first quarter ended March 31, 2022 before the market opens on May
Harvard Bioscience Schedules First Quarter 2022 Earnings Conference Call for May 4, 2022 at 8:00 AM ET
04:05pm, Thursday, 21'st Apr 2022
HOLLISTON, Mass., April 21, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for first quarter ended March 31, 2022 before the market opens on May 4
